Actively Recruiting
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2025-05-18
300
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective, single-center clinical trial. It aims to establish an improved robotic-assisted radical prostatectomy for treating locally advanced prostate cancer. The technique evaluates the impact of preserving the anterior peritoneum of the bladder on postoperative bladder descent and urinary control recovery. A retrospective analysis compares this modified approach with traditional anterior approach surgery, assessing differences in oncological outcomes, early functional recovery, and postoperative complication rates. The goal is to provide new theoretical foundations and technical support for the prevention and treatment of postoperative urinary incontinence.
CONDITIONS
Official Title
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prostate biopsy and clinical confirmation of high-risk prostate cancer (PSA > 20 ng/mL, Gleason score 65 8, or cT stage 65 T2c) followed by robotic-assisted radical prostatectomy
- Multiparametric MRI (mpMRI) with a 3.0 T scanner for prostate or pelvic scans performed within 30 days before the operation at the study center
- Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1
- Complete clinical and prostate biopsy pathological data
- General health is good, with no infections, autoimmune diseases, hematologic disorders, or other malignancies
You will not qualify if you...
- Presence of surgical contraindications
- Refusal of enhanced mpMRI imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, China, 350005
Actively Recruiting
Research Team
X
Xu Ning, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here